Although this class of drugs, called glucagon-like peptide-1 or GLP-1, have been around for more than 17 years, with the first one, Byetta, approved in 2005, it is only recently that the class has made a big name for itself with the introduction of the popular once-weekly diabetic drug, Ozempic , and the equally popular obesity drug, Wegovy (the same drug as Ozempic but with a different dose)
Taylor Kantor
Tirzepatide left out of the fridge is a common concern for patients using this temperature-sensitive medication
As with all GLP-1s, Saxenda and Ozempic start at a low dose to reduce side effects
If any of the following apply to you, you should avoid taking Ozempic for weight loss: If youre interested in taking Ozempic to help lose weight and any of the above symptoms or conditions apply to you, talk to your healthcare provider about alternatives that may be appropriate
58.6% of people on the 12 mg dose lost at least 25% of their body weight